Clinical trials
Phase 2 Community-Acquired Pneumonia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2020 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 3 |
| Withdrawn | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biotest | 2 |
| TaiGen Biotechnology Co., Ltd. | 2 |
| Aptarion Biotech AG | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Enanta Pharmaceuticals, Inc | 1 |
| Enlivex Therapeutics Ltd. | 1 |
| GlaxoSmithKline | 1 |
| Gordon Bernard | 1 |
| Hellenic Institute for the Study of Sepsis | 1 |
| IASO Pharma Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Community-Acquired Pneumonia | 22 |
| Pneumonia | 5 |
| Sepsis | 4 |
| COVID-19 | 2 |
| Respiratory Distress Syndrome | 2 |
| Bacterial Infections | 1 |
| Cholecystitis, Acute | 1 |
| Cognition Disorders | 1 |
| Healthcare-Associated Pneumonia | 1 |
| Influenza, Human | 1 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.